BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2016
View Archived Issues
[18F]MK-6240: a PET tracer for the quantification of human neurofibrillary tangles
Read More
Vaxart begins phase I trial of oral RSV vaccine
Read More
PET using novel [18]F-AmBF3-PSMA derivatives clearly reveals prostate cancer in mice
Read More
Shire reports topline clinical results on SHP-465
Read More
FDA grants fast track designation to ONT-380
Read More
FDA clears Xpert Carba-R Assay
Read More
Lipocine receives complete response letter for LPCN-1021
Read More
Merck & Co. and Moderna enter collaboration for novel mRNA-based personalized cancer vaccines
Read More
Japan Tobacco prepares launch of Genvoya combination tablets in Japan
Read More
Galena Biopharma discontinues phase III PRESENT trial after interim analysis
Read More
OncBioMune highlights promising progress in cancer vaccine development
Read More
Actinium Pharmaceuticals initiates phase III SIERRA study
Read More
ACRAF patents DNA gyrase and DNA topoisomerase IV inhibitors
Read More
Cara Therapeutics discloses phase II results on CR-845
Read More
Bayer Schering Pharma discloses Mnk1 inhibitors
Read More
Janssen Pharmaceutica describes PI3Kbeta inhibitors
Read More
Roche patent reveals TLR8 agonists
Read More
Evotec presents P2X3 receptor antagonists
Read More
Cytune Pharma closes financing round
Read More
NOVA phase III trial successfully achieves primary endpoint in patients with ovarian cancer
Read More
NCI grant supports BioMarker Strategies' development of PathMAP NSCLC companion diagnostic test
Read More
Xcovery initiates phase III trial of X-396 in ALK-positive NSCLC
Read More
Imbruvica obtains FDA breakthrough therapy designation for new indication
Read More
Stempeucel shows efficacy for the treatment of CLI due to Buerger's disease
Read More
SER-262 prevents recurrence in patients with primary CDI
Read More
European Commission grants orphan drug designation to BPS-804 for osteogenesis imperfecta
Read More